scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.UROLONC.2013.11.010 |
P698 | PubMed publication ID | 24495451 |
P50 | author | Shahrokh Shariat | Q7462263 |
Marek Babjuk | Q12035273 | ||
Tobias Klatte | Q88250588 | ||
Morgan Rouprêt | Q88883209 | ||
Pierre I Karakiewicz | Q97332033 | ||
Evanguelos Xylinas | Q101135017 | ||
Malte Rieken | Q114316459 | ||
Harun Fajkovic | Q114316461 | ||
Yair Lotan | Q61862568 | ||
P2093 | author name string | Christian Seitz | |
Michela de Martino | |||
P2860 | cites work | Loss of blood group A antigen expression in bladder cancer caused by allelic loss and/or methylation of the ABO gene | Q81725657 |
Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients | Q84072813 | ||
Prognostic markers for urothelial cancer: obstacles and opportunities | Q84483420 | ||
Age ≥ 80 years is independently associated with survival outcomes after radical cystectomy: results from the Canadian Bladder Cancer Network Database | Q84883989 | ||
Cancer statistics, 2013 | Q27860762 | ||
Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer | Q33783766 | ||
What a difference 2 nucleotides make: a short review of ABO genetics | Q36190639 | ||
ABO blood group and breast cancer incidence and survival | Q36848913 | ||
ABO blood group and the risk of pancreatic cancer | Q37131928 | ||
Comprehensive handbook for developing a bladder cancer cystectomy database | Q37953115 | ||
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder | Q38037276 | ||
Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis | Q43625088 | ||
Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a. | Q44793009 | ||
Evaluation of ABO blood group as a prognostic marker in renal cell carcinoma (RCC). | Q45084644 | ||
International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy | Q46165799 | ||
Relationship between blood groups and tumour grade, number, size, stage, recurrence and survival in patients with transitional cell carcinoma of the bladder | Q47401730 | ||
ABO blood group and risk of renal cell cancer. | Q55144611 | ||
ABO blood groups and bladder carcinoma | Q68841708 | ||
Role of blood groups as prognostic factors in primary breast cancer | Q68846205 | ||
Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study | Q68859402 | ||
Influence of blood group type on the natural history of superficial bladder cancer | Q69403406 | ||
Relationship of blood groups and bladder cancer | Q69991102 | ||
Double blind comparison of T-antigen and ABO(H) cell surface antigens in bladder cancer | Q70335902 | ||
Clinicopathologic correlations of ABO and Rhesus blood type in colorectal cancer | Q70521414 | ||
Genotypic and phenotypic characterization of the histoblood group ABO(H) in primary bladder tumors | Q74323839 | ||
P433 | issue | 5 | |
P921 | main subject | Radical cystectomy | Q111329312 |
P304 | page(s) | 625-630 | |
P577 | publication date | 2014-02-02 | |
P1433 | published in | Urologic Oncology | Q2113446 |
P1476 | title | Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy | |
P478 | volume | 32 |
Q52569036 | A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer. |
Q64966406 | ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity. |
Q50225627 | Development of a Preoperative Nomogram Incorporating Biomarkers of Systemic Inflammatory Response to Predict Nonorgan-confined Urothelial Carcinoma of the Bladder at Radical Cystectomy. |
Q36176989 | Impact of surgical margin status on the outcome of bladder cancer treated by radical cystectomy: a meta-analysis |
Q55000620 | Prognostic role of ABO blood group in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization. |
Q41056921 | Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent |
Q51487533 | Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer. |
Q50943065 | Prognostic value of Ki67 and p63 expressions in bladder cancer patients who underwent radical cystectomy. |
Q41432872 | The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy |
Q48007072 | The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma. |
Q49407223 | The impact of perioperative blood transfusion on survival outcomes in radical cystectomy patients |
Q53574858 | The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy. |
Q38901440 | The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder |
Q26775411 | The prognostic value of ABO blood group in cancer patients |
Q53185271 | Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution. |
Q89017427 | Validating the role of ABO blood type in risk of perioperative venous thromboembolism after radical cystectomy |
Search more.